Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2010

Open Access 01-12-2010 | Case Report

Chronological changes of the amplitude-integrated EEG in a neonate with molybdenum cofactor deficiency

Authors: Sintha D. Sie, Rogier C. J. de Jonge, Henk J. Blom, Margot F. Mulder, Jochen Reiss, R. J. Vermeulen, Cacha M. P. C. D. Peeters-Scholte

Published in: Journal of Inherited Metabolic Disease | Special Issue 3/2010

Login to get access

Abstract

Molybdenum cofactor (Moco) deficiency is a rare neurometabolic disorder, characterized by neurological impairment and refractive seizures, due to toxic accumulation of sulfite in the brain. Earlier it was suggested that in Moco-deficient humans maternal clearance of neurotoxic metabolites prevents prenatal brain damage. However, limited data are available about the time profile in which neurophysiologic deterioration occurs after birth. The amplitude-integrated electroencephalography (aEEG) is a bedside method in neonates to monitor cerebral recovery after hypoxic-ischemic insults, detect epileptic activity, and evaluate antiepileptic drug treatment. We describe a chronological series of changes in aEEG tracings in a neonate with Moco deficiency. He presented with myoclonic spasms and hypertonicity a few hours after birth, however, the aEEG pattern was still normal. Within 2 days, the aEEG rapidly changed into a burst suppression pattern with repetitive seizures. After antiepileptic treatment, the aEEG remained abnormal. In this patient, the normal aEEG pattern at birth may have been due to maternal clearance of sulfite in utero. After birth, accumulation of sulfite causes progressive brain damage, reflected by the progressive depression of the aEEG tracings. This is in agreement with the results from a Moco-deficient mouse model, suggesting that maternal sulfite clearance suppresses prenatal brain damage. To our knowledge, this is the first case report describing the chronological changes in the aEEG pattern in a Moco-deficient patient. Insight into the time profile in which neurologic deterioration in Moco-deficient humans occurs is essential, especially when potential treatment strategies are being evaluated.
Literature
go back to reference Hellstrom-Westas L, Rosen I (2006) Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 11:503–511PubMedCrossRef Hellstrom-Westas L, Rosen I (2006) Continuous brain-function monitoring: state of the art in clinical practice. Semin Fetal Neonatal Med 11:503–511PubMedCrossRef
go back to reference Johnson JL (2003) Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. Prenat Diagn 23:6–8PubMedCrossRef Johnson JL (2003) Prenatal diagnosis of molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. Prenat Diagn 23:6–8PubMedCrossRef
go back to reference Johnson JL, Duran M (2001) Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beander AL, Valle D, Sly WS (eds) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York, pp 3163–3177 Johnson JL, Duran M (2001) Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beander AL, Valle D, Sly WS (eds) The metabolic & molecular bases of inherited disease. McGraw-Hill, New York, pp 3163–3177
go back to reference Reiss J, Johnson JL (2003) Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Hum Mutat 21:569–576PubMedCrossRef Reiss J, Johnson JL (2003) Mutations in the molybdenum cofactor biosynthetic genes MOCS1, MOCS2, and GEPH. Hum Mutat 21:569–576PubMedCrossRef
go back to reference Reiss J, Bonin M, Schwegler H et al. (2005) The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis. Mol Genet Metab 85:12–20PubMedCrossRef Reiss J, Bonin M, Schwegler H et al. (2005) The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysis. Mol Genet Metab 85:12–20PubMedCrossRef
go back to reference Schwarz G, Santamaria-Araujo JA, Wolf S et al. (2004) Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli. Hum Mol Genet 13:1249–1255PubMedCrossRef Schwarz G, Santamaria-Araujo JA, Wolf S et al. (2004) Rescue of lethal molybdenum cofactor deficiency by a biosynthetic precursor from Escherichia coli. Hum Mol Genet 13:1249–1255PubMedCrossRef
go back to reference Schwarz G, Mendel RR, Ribbe MW (2009) Molybdenum cofactors, enzymes and pathways. Nature 460:839–847PubMedCrossRef Schwarz G, Mendel RR, Ribbe MW (2009) Molybdenum cofactors, enzymes and pathways. Nature 460:839–847PubMedCrossRef
go back to reference Serrano M, Lizarraga I, Reiss J et al. (2007) Cranial ultrasound and chronological changes in molybdenum cofactor deficiency. Pediatr Radiol 37:1043–1046PubMedCrossRef Serrano M, Lizarraga I, Reiss J et al. (2007) Cranial ultrasound and chronological changes in molybdenum cofactor deficiency. Pediatr Radiol 37:1043–1046PubMedCrossRef
go back to reference Teksam O, Yurdakok M, Coskun T (2005) Molybdenum cofactor deficiency presenting with severe metabolic acidosis and intracranial hemorrhage. J Child Neurol 20:155–157PubMedCrossRef Teksam O, Yurdakok M, Coskun T (2005) Molybdenum cofactor deficiency presenting with severe metabolic acidosis and intracranial hemorrhage. J Child Neurol 20:155–157PubMedCrossRef
go back to reference Toet MC, van der Meij W, de Vries LS, Uiterwaal CS, van Huffelen KC (2002) Comparison between simultaneously recorded amplitude integrated electroencephalogram (cerebral function monitor) and standard electroencephalogram in neonates. Pediatrics 109:772–779PubMedCrossRef Toet MC, van der Meij W, de Vries LS, Uiterwaal CS, van Huffelen KC (2002) Comparison between simultaneously recorded amplitude integrated electroencephalogram (cerebral function monitor) and standard electroencephalogram in neonates. Pediatrics 109:772–779PubMedCrossRef
go back to reference van Leuven K, Groenendaal F, Toet MC et al. (2004) Midazolam and amplitude-integrated EEG in asphyxiated full-term neonates. Acta Paediatr 93:1221–1227PubMedCrossRef van Leuven K, Groenendaal F, Toet MC et al. (2004) Midazolam and amplitude-integrated EEG in asphyxiated full-term neonates. Acta Paediatr 93:1221–1227PubMedCrossRef
go back to reference Veldman A, Santamaria-Araujo JA, Sollazzo S et al. (2010) Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 125:e1249–e1254PubMedCrossRef Veldman A, Santamaria-Araujo JA, Sollazzo S et al. (2010) Successful treatment of molybdenum cofactor deficiency type A with cPMP. Pediatrics 125:e1249–e1254PubMedCrossRef
go back to reference Wezel-Meijler G, Steggerda SJ, Leijser LM (2010) Cranial ultrasonography in neonates: role and limitations. Semin Perinatol 34:28–38PubMedCrossRef Wezel-Meijler G, Steggerda SJ, Leijser LM (2010) Cranial ultrasonography in neonates: role and limitations. Semin Perinatol 34:28–38PubMedCrossRef
Metadata
Title
Chronological changes of the amplitude-integrated EEG in a neonate with molybdenum cofactor deficiency
Authors
Sintha D. Sie
Rogier C. J. de Jonge
Henk J. Blom
Margot F. Mulder
Jochen Reiss
R. J. Vermeulen
Cacha M. P. C. D. Peeters-Scholte
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue Special Issue 3/2010
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9198-z

Other articles of this Special Issue 3/2010

Journal of Inherited Metabolic Disease 3/2010 Go to the issue